Whitepaper Oct 7, 2026 Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation
Press Release Oct 22, 2026 Lumanity Unveils AI-Enabled Intelligence Platform Engineered to Transform Value Demonstration Across the Lifecycle of a Medicine
Press Release Jul 7, 2026 Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets initiative) Validation For Near-Term Emissions Reduction Targets
Whitepaper Oct 7, 2026 Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation
Press Release Oct 22, 2026 Lumanity Unveils AI-Enabled Intelligence Platform Engineered to Transform Value Demonstration Across the Lifecycle of a Medicine
Press Release Jul 7, 2026 Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets initiative) Validation For Near-Term Emissions Reduction Targets
Case Study Jan 14, 2022 First Successful HTA Submission to G-BA to Include an Indirect Treatment Comparison for an Immune-oncology Treatment in Adjuvant Melanoma
Case Study Jan 14, 2022 Readiness in a CNS Gene Therapy Biotech to Engage with Potential Partners Through Guidance on Partnering Strategy, Deal Value/Structure, and Materials
Case Study Nov 24, 2021 Understanding the Strategy Behind Viral Vector Selection in Ex Vivo and In Vivo Gene Therapies
Case Study Oct 24, 2021 Activating Medical Affairs to Drive Competitive Differentiation Over the Pre-Launch to Early Post-Launch Period
Case Study Sep 20, 2021 Go-To-Market (GTM): Market-Shaping Launch Commercialization Planning for a Gene Therapy Asset in a Congenital Rare Disease Therapy Area
Case Study Aug 26, 2021 Competitor Scenario Planning and Mitigation Strategy Development for Launch Commercialization
Case Study Jul 19, 2021 Developing the First EMEA Cross-Functional Strategic Plan for an Autologous CAR T-Cell Therapy Asset with a Newly-Formed Launch Commercialization Team (T-30 months)
Case Study Jun 22, 2021 Establishing an Organization-Wide Annual Strategic and Tactical Brand-Planning Process
Case Study May 25, 2021 Bioethics Landscape Analysis for Cell Therapies and Resultant Baseline Lexicon Development, as Part of Strategy Planning for Early-Asset Commercialization